(Q84701621)
Statements
Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk (English)
A F H Stalenhoef
M H Davidson
J G Robinson
T Burgess
R Duttlinger-Maddux
D Kallend
A C Goldberg
21 November 2011